Skip to content

Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study

Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05693363
Acronym
ThorPET
Enrollment
40
Registered
2023-01-23
Start date
2024-01-01
Completion date
2025-07-31
Last updated
2025-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Neoplasms, PET-CT Specimen Imager

Brief summary

In this pilot study the investigators propose the intraoperative use of a high-resolution PET-CT imaging system which can assess resection margins and lymph node status in the operating room. This will allow for a faster and stepwise assessment (estimated to be under 10 minutes per specimen), enabling the surgeon to decide on subsequent surgical steps after each previous assessment.

Interventions

DEVICEAURA10 Specimen Imager

High-resolution specimen imaging using the AURA10 PET-CT specimen imager during thoracic surgery.

Sponsors

XEOS Medical
CollaboratorINDUSTRY
University Hospital, Ghent
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is 18 years of age or older. * Patient with suspected or confirmed lung malignancies * Patient is indicated to undergo thoracic surgery. * Patient is estimated to be compliant for study participation by the investigator. * Patient has freely given his/her informed consent to participate in this study.

Exclusion criteria

* Patient has general or local contra-indications for thoracic surgery. * Patient has active infection. * Blood glucose level over 200 mg/dL on the day of surgery. * Pregnancy or lactation. * Patient participated in other clinical studies with radiation exposure of more than 1 mSv in the past year

Design outcomes

Primary

MeasureTime frameDescription
Perioperative success in imaging utilizing AURA10 PET-CT Specimen ImagerPerioperativeA measure of perioperative success in imaging 18F-FDG- uptake in resected specimens obtained during thoracic surgery utilizing a high-resolution PET-CT-scanner.

Secondary

MeasureTime frame
Sensitivity and specificity of high-resolution 18F-FDG-PET-CT of resected lung tumors in terms of bronchial margin assessment.Perioperative
Sensitivity and specificity of high-resolution 18F-FDG-PET-CT of resected lung tumors in terms of lung parenchyma margin assessmentPerioperative
Correlation between 18F-FDG uptake in the resected specimens and histopathological characteristics of the tumor, such as the type, grade, or stage of the tumor.Perioperative
Sensitivity and specificity of high-resolution 18F-FDG-PET-CT of resected mediastinal or thoracic lymph nodes in terms of nodal staging.Perioperative
Comparison of lesion dimensions (e.g. delineation based on percentage of SUVmax, tumor-to-background ratios based on SUVpeak).Perioperative
Occupational radiation exposure (µSv) to the staff in the operating room related to this study.Perioperative
Correlation of high-resolution 18F-FDG-PET-CT images of lamellas of the resected specimen with histopathological whole-slide images.Perioperative
Measure signal-to-noise ratio on post-processed PET-CT specimen images.Perioperative

Countries

Belgium

Contacts

Primary ContactLiesbeth Desender, prof. dr.
liesbeth.desender@uzgent.be+32 9 332 63 88
Backup ContactLina Vermeir
studiestvhk@uzgent.be+32 9 332 62 58

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026